Automatic treatment planning of VMAT for left-sided breast cancer with lymph nodes.

BACKGROUND: The standard in Denmark for treating breast cancer patients receiving loco-regional irradiation is tangential 3D Conformal RadioTherapy (3DCRT), treated in deep inspiration breath-hold (DIBH). Treating with Volumetric Modulated Arc Therapy (VMAT) may reduce the treatment time, which is particularly important for DIBH treatments. The VMAT should be performed without increased dose to the heart, lung, and contralateral breast. This study compares VMAT and 3DCRT for left-sided breast cancer patients with intramammary lymph node involvement. MATERIAL AND METHODS: Twenty left-sided breast cancer patients were included. VMAT and tangential plans were created for all patients, with a prescription dose of 50 Gy. The tangential plans used 6 MV and for larger breast combined with 18 MV. The VMAT plans utilised two 6 MV fields in a butterfly configuration. Dose planning was done in Pinnacle3 16.0 using the Auto-Planning module for the VMAT plans. Comparison of the plans was based on: mean doses, metrics provided by DBCG guidelines, dose-volume histograms and required number of breath-holds for treatment delivery in DIBH. RESULTS: For most OAR, the doses were similar for VMAT and 3DCRT. The target coverage was comparable, with VMAT having a statistically significant improved dose homogeneity of the target volumes. Less than half the number of breath-hold was required for VMAT compared to 3DCRT. Mean gamma pass rates (3 mm and 3%) from ArcCHECK of the VMAT plans was 98.4% (range 96.6-99.8%). CONCLUSION: Automatic VMAT planning of left-sided breast cancer patients with lymph node involvement can produce dose distributions comparable to those of tangential 3DCRT, while reducing the number of breath-holds in DIBH by more than a factor of two. The reduction in breath-holds is beneficial for patient comfort and reduces the risk of intra-fraction patient motion.

First clinical experiences with a high field 1.5 T MR linac.

Purpose: A 1.5 T MR Linac (MRL) has recently become available. MRL treatment workflows (WF) include online plan adaptation based on daily MR images (MRI). This study reports initial clinical experiences after five months of use in terms of patient compliance, cases, WF timings, and dosimetric accuracy. Method and materials: Two different WF were used dependent on the clinical situation of the day; Adapt To Position WF (ATP) where the reference plan position is adjusted rigidly to match the position of the targets and the OARs, and Adapt To Shape WF (ATS), where a new plan is created to match the anatomy of the day, using deformable image registration. Both WFs included three 3D MRI scans for plan adaptation, verification before beam on, and validation during IMRT delivery. Patient compliance and WF timings were recorded. Accuracy in dose delivery was assessed using a cylindrical diode phantom. Results: Nineteen patients have completed their treatment receiving a total of 176 fractions. Cases vary from prostate treatments (60Gy/20F) to SBRT treatments of lymph nodes (45 Gy/3F) and castration by ovarian irradiation (15 Gy/3F). The median session time (patient in to patient out) for 127 ATPs was 26 (21-78) min, four fractions lasted more than 45 min due to additional plan adaptation. For the 49 ATSs a median time of 12 (1-24) min was used for contouring resulting in a total median session time of 42 (29-91) min. Three SBRT fractions lasted more than an hour. The time on the MRL couch was well tolerated by the patients. The median gamma pass rate (2 mm,2% global max) for the adapted plans was 99.2 (93.4-100)%, showing good agreement between planned and delivered dose. Conclusion: MRL treatments, including daily MRIs, plan adaptation, and accurate dose delivery, are possible within a clinically acceptable timeframe and well tolerated by the patients.

Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT.

BACKGROUND: To investigate whether a standard Cone beam CT (CBCT) scan can be used to determined the intra- and inter-fractional tumour motion for lung tumours that have infiltrated the mediastinum. MATERIAL AND METHODS: This study includes 23 patients with non small cell lung cancer (NSCLC). The intra-fractional tumour motion was analysed for each patient on a 4D-CT scan as well as on three 4D-CBCT (fraction 3, 10 and 20). The 4D-CBCT was reconstructed from a standard 3D-CBCT using in-house developed software. The tumour (GTV) was delineated in the first phase of the 4D-CT. Registration of phase one from the 4D-CT and 4D-CBCT was used to copy the GTV to the CBCT scans. Hereafter the motion of the outlined GTV was tracked in the planning 4D-CT and the three 4D-CBCT using Pinnacle(®) version 8.1w (research version). Additionally, the inter-fractional tumour movement, relative to the bony structure, was obtained from the difference in tumour position between the 3D-CT and the standard 3D-CBCT. RESULTS: It is possible to track a lung tumour with mediastinal infiltration in the 4D-CBCT scan based on a standard 3D-CBCT. The respiration motion in the 4D-CBCT is not significantly different from the result found from the initial 4D-CT. Likewise, no differences in respiration motion was found between fractions 3, 10 and 20. CONCLUSION: This study shows that it is possible to track tumour motion for NSCLC patients with mediastinal infiltration using a standard 3D-CBCT. No change in the intra-fractional tumour motion of clinically relevance was observed during the fractionated treatment course. The inter-fractional tumour motion found underlines the importance of using daily IGRT with online match on soft tissue in order to be able to reduce treatment margins.